Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.0.1
Consolidated Balance Sheets - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Current Assets    
Cash and Cash Equivalents, at Cost, Which Approximates Fair Value $ 354,500,000 $ 519,600,000
Short-Term Investments in Marketable Securities 800,000 56,700,000
Total Cash and Short-Term Investments in Marketable Securities 367,500,000 587,000,000.0
Accounts and Notes Receivable, Less Allowances of $11.3 and $9.2 485,300,000 337,600,000
Inventories    
Finished Goods 685,500,000 446,800,000
Work-In-Process 176,800,000 94,000,000.0
Raw Materials 345,700,000 171,000,000.0
Net Inventories 1,208,000,000 711,800,000
Prepaid Expenses and Other 63,800,000 34,100,000
Current Assets 2,124,600,000 1,670,500,000
Property    
Land 34,700,000 17,700,000
Buildings and Improvements 479,300,000 435,500,000
Equipment 1,332,400,000 1,184,900,000
Total Land, Buildings and Improvements and Equipment 1,846,400,000 1,638,100,000
Accumulated Depreciation (989,600,000) (929,800,000)
Net Land, Buildings and Improvements and Equipment 856,800,000 708,300,000
Unamortized Product Tooling Costs 190,100,000 155,300,000
Net Property 1,046,900,000 863,600,000
Other Assets    
Goodwill 888,400,000 417,700,000
Other Intangibles, Net 1,052,100,000 552,300,000
Equity Investments 43,800,000 32,500,000
Deferred Revenue 146,000,000.0 136,600,000
Operating lease assets 92,800,000 83,000,000.0
Other long-term assets 30,400,000 14,400,000
Other Assets 2,253,500,000 1,236,500,000
Total Assets 5,425,000,000 3,770,600,000
Current Liabilities    
Short-Term Debt and Current Maturities of Long-Term Debt 37,400,000 43,100,000
Accounts Payable 693,500,000 457,600,000
Accrued Expenses 711,300,000 578,500,000
Current Liabilities 1,442,200,000 1,079,200,000
Long-Term Liabilities    
Debt 1,779,000,000 908,300,000
Non-Current Operating Lease Liabilities 75,500,000 69,800,000
Postretirement Benefits 66,500,000 74,700,000
Other 147,600,000 128,600,000
Long-Term Liabilities 2,068,600,000 1,181,400,000
Shareholders' Equity    
Common Stock; Authorized: 200,000,000 Shares, $0.75 Par Value; Issued: 102,538,000 Shares; Outstanding: 86,757,000 and 87,537,000 Shares 76,900,000 76,900,000
Additional Paid-In Capital 394,500,000 383,800,000
Retained Earnings 2,720,100,000 2,225,700,000
Treasury Stock, at Cost: 15,781,000 and 15,001,000 Shares (1,245,800,000) (1,133,700,000)
Accumulated Other Comprehensive Loss, Net of Tax:    
Foreign Currency Translation (34,500,000) (15,100,000)
Prior Service Credits (3,700,000) (3,500,000)
Net Actuarial Losses (3,400,000) (8,900,000)
Unrealized Gain (Loss) on Investments 200,000 0
Unrealized Losses on Derivatives 9,900,000 (15,200,000)
Total Accumulated Other Comprehensive Loss, Net of Tax (31,500,000) (42,700,000)
Shareholders' Equity 1,914,200,000 1,510,000,000
Total Liabilities and Shareholders' Equity $ 5,425,000,000 $ 3,770,600,000
Common Stock, Shares Authorized (in Shares) 200,000,000 200,000,000
Common Stock, Par Value (in Dollars per Share) $ 0.75 $ 0.75
Common Stock, Shares Outstanding 76,933,000 77,875,000
Common Stock, Shares Issued (in Shares) 102,538,000 102,538,000
Treasury Stock, Shares (in Shares) 25,605,000 24,663,000
Accounts and Notes Receivable, Allowances $ 9,700,000 $ 10,700,000
Less: Restricted Cash $ 12,200,000 $ 10,700,000